O'Shaughnessy & the Western Rediscovery of Cannabis (1839)

Western medicine did not discover cannabis. Indian, Persian, and Chinese physicians had used it for centuries. What happened in 1839 was that one unusually rigorous colonial physician translated that knowledge into the language of European clinical medicine and carried physical specimens back to London. Within two decades, cannabis was listed in the pharmacopoeias of multiple Western nations. Within a generation, over a hundred scientific articles described its therapeutic properties. The catalyst for all of this was a single paper read before a medical society in Calcutta.

The physician

William Brooke O'Shaughnessy (1809–1889) was born in Limerick, Ireland, and trained at the University of Edinburgh, where he earned distinction as a forensic chemist. He entered the service of the East India Company and arrived in Calcutta as a young surgeon, bringing with him the rigorous empiricism of the Edinburgh medical school — then arguably the finest in Europe.

O'Shaughnessy was not a one-subject physician. Over his career in India he would design the subcontinent's telegraph network, for which he was knighted in 1856. But his enduring contribution to medical history was a paper on a plant the British had been growing in Bengal for decades without investigating its therapeutic potential.

The paper

The full and correct title of O'Shaughnessy's paper — frequently miscited in popular histories as a "Bengal Medical Journal" article — is "On the Preparations of the Indian Hemp, or Gunjah (Cannabis Indica); Their Effects on the Animal System in Health, and their Utility in the Treatment of Tetanus and other Convulsive Diseases." It was published in the Transactions of the Medical and Physical Society of Bengal, volume 8 (1838–40), pages 421–461, with a monograph issued the same year by Bishop's College Press, Calcutta, and a European reprint in the Provincial Medical Journal in 1843.

The paper's structure was methodical. O'Shaughnessy began by surveying existing Ayurvedic and Persian materia medica — documenting what Indian and Islamic physicians already knew about the plant's effects. He was not starting from zero. He was translating an existing body of knowledge into the empirical framework that Edinburgh-trained physicians demanded.

The animal experiments

Before testing cannabis on any human subject, O'Shaughnessy conducted a series of animal experiments that was extensive for its era. He administered cannabis preparations to dogs, cats, swine, fish, vultures, horses, and monkeys, recording their reactions with clinical precision. He observed a striking pattern: carnivorous animals intoxicated readily, while herbivores showed little effect — a pharmacological distinction that remains broadly consistent with modern understanding of species-specific cannabinoid receptor expression.

These animal trials were not idle curiosity. O'Shaughnessy was building a safety profile before human administration — a methodological instinct that, while primitive by modern standards, placed him ahead of many of his contemporaries who tested drugs on patients first and animals never.

The human trials

Satisfied by his animal experiments, O'Shaughnessy moved to human trials, administering cannabis preparations for rheumatism, cholera, hydrophobia (rabies), and — most importantly — tetanus and infantile convulsions.

His most celebrated case involved a forty-day-old infant suffering from severe convulsions. O'Shaughnessy treated the child with escalating doses of cannabis resin. The infant fell into a calm sleep and recovered. Cannabis, he concluded, offered "an anti-convulsive remedy of the greatest value."

O'Shaughnessy did not claim cannabis was a cure for everything. He reported failures alongside successes, and his dosing notes reflect genuine uncertainty about appropriate concentrations. The paper reads as honest clinical observation, not as advocacy.

Bringing cannabis to England

Returning to England on sick leave from 1841 to 1844, O'Shaughnessy carried hemp specimens to the Royal Botanic Gardens at Kew — ensuring the plant's availability for European botanical study and pharmaceutical development. He then worked with London pharmacist Peter Squire to produce the first standardized alcoholic tincture of cannabis, which became known as "Squire's Extract."

Squire's Extract represented a critical step. The perennial problem with cannabis as medicine — one that would plague the pharmaceutical industry throughout the nineteenth century — was variability. Different batches of plant material produced wildly different potencies. Squire and O'Shaughnessy attempted to create a consistent, reliable preparation, and while their standardization was imperfect by modern measures, it was sufficient to make cannabis a practical clinical tool for British and European physicians.

The cascade effect

O'Shaughnessy's paper opened a floodgate. European and American physicians began investigating cannabis with genuine enthusiasm. By 1900, as Lester Grinspoon later counted, more than one hundred articles had appeared in scientific journals describing the medicinal properties of the plant.

The United States Pharmacopoeia admitted cannabis in 1850 — just eleven years after O'Shaughnessy's paper. The British Pharmacopoeia followed in the 1860s. Major pharmaceutical firms including Parke-Davis, Eli Lilly, E.R. Squibb, and Burroughs Wellcome developed commercial cannabis preparations. None of this would have happened without O'Shaughnessy's foundational work.

The man beyond the paper

O'Shaughnessy's later career was, if anything, more consequential in India than his cannabis research. He designed and built much of the Indian telegraph system, a project of staggering logistical ambition that connected the subcontinent by wire and earned him a knighthood in 1856. He died in 1889, having lived long enough to see cannabis become a routine medicine in Western practice — but not long enough to see it criminalized.

His contribution to cannabis history is precise and documentable: he did not discover a new drug, but he translated an ancient one into the language of Western empirical medicine. That translation opened a half-century of legitimate therapeutic use — and makes O'Shaughnessy, more than any other single individual, the founder of Western cannabis therapeutics.